Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
01/2004
01/02/2004EP1372615A1 Compounds and compositions for delivering active agents
01/02/2004EP1372591A1 Kits for whitening teeth
01/02/2004EP1372412A2 Composition improving age-related physiological deficits and increasing longevity
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002159 Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof
01/01/2004US20040002117 Immunosuppressive agents of given formula; prevents dephosphorylation
12/2003
12/31/2003WO2004000366A1 Pegylated factor vii glycoforms
12/31/2003WO2004000341A1 The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof
12/31/2003WO2004000316A1 Use of mglur5 antagonists for the treatment of gerd
12/31/2003WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2003072576A3 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003CN1463735A Drug rehabilitation oral liquid
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490100A1 Pharmaceutical formulation for use in treating drug withdrawal and preparation method
12/30/2003CA2175971C Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
12/30/2003CA2093806C Method of treating or preventing type 1 diabetes by oral administration of insulin
12/30/2003CA2076063C Sulfated glycosaminoglycanoid derivatives
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236236 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
12/25/2003US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine
12/25/2003US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins
12/25/2003US20030235607 Compositions and methods for inhibiting fungal growth and transference
12/25/2003US20030235595 Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
12/24/2003WO2003106491A2 Cell penetrating peptides
12/24/2003WO2003105761A2 Immunotoxin as a therapeutic agent and uses thereof
12/24/2003DE10225635C1 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung N-Benzoylureido-cinnamic acid derivatives, processes for their preparation and their use
12/24/2003CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof
12/24/2003CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate
12/24/2003CA2488858A1 Immunotoxin as a therapeutic agent and uses thereof
12/23/2003US6667344 Formoterol, or a derivative; long term storage stability
12/23/2003US6667332 Benzisoxazolyl-pyrazole derivatives formed by salt formation with maleic acid and hydrochloric acid and cyclization with acetohydroxamic acid
12/23/2003US6666212 Intraoral discluder device and method for preventing migraine and tension headaches and temporomandibular disorders
12/23/2003CA2234964C A depilatory composition with improved rinsing properties
12/23/2003CA2147172C Transdermal therapeutic system for the release of 17-.beta.-estradiol and process for its production
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104188A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/18/2003WO2003103714A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
12/18/2003WO2003103708A1 BIOFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/18/2003WO2003103605A2 Flexible vaccine assembly and vaccine delivery platform
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103592A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003047511A3 Use of gingko biloba extracts to promote neuroprotection and reduce weight loss
12/18/2003US20030232814 Novel compounds and their use
12/18/2003CA2488760A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/18/2003CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003CA2487889A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
12/18/2003CA2486118A1 Flexible vaccine assembly and vaccine delivery platform
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP0806938B1 Powder for use in dry powder inhalers
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof
12/17/2003CN1131309C IL-6 mutein
12/17/2003CN1131229C Salt of naphthyridine carboxylic acid derivative
12/17/2003CN1131228C Benzo (5,6) cyclohepta (1,2-6) pyridine derivs. for inhibition of farnesy-protein transferase
12/16/2003US6664424 Stereoscopically-pure stereoisomer; use relieving nasal, sinus and bronchial congestion and of treating attention deficit hyperactivity disorder and obesity; also use to induce pupil dilation
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/11/2003WO2003102116A2 Oil-soluble pigment compositions
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101432A1 Combination immediate release controlled release levodopa/carbidopa dosage forms
12/11/2003WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229062 Treatments for age-related macular degeneration (AMD)
12/11/2003US20030229031 13-Methyl erythromycin derivatives
12/11/2003US20030229027 In mixture of sugar and,or sugar alcohol
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer
12/11/2003US20030228360 Combination immediate release controlled release levodopa/carbidopa dosage forms
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487509A1 New salts
12/11/2003CA2486424A1 Oil-soluble pigment compositions
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368030A1 Epothilone derivatives for the treatment of refractory tumors
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003CN1130346C Tetrahydroquinolines as NMDA antagonists
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660304 Method of treating prickly heat
12/09/2003US6660045 Hair colorant preparation
12/09/2003CA2387284C Chinese herbs extract
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099302A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
12/04/2003WO2003099281A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes
12/04/2003WO2003099229A2 Functional protein expression for rapid cell-free phenotyping
12/04/2003WO2003099219A2 Bryostatins, bryopyrans and polyketides: compositions and methods
12/04/2003WO2003099215A2 Antisense modulation of glucocorticoid receptor expression
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003088920A3 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
12/04/2003WO2003059807A3 Crystalline solids of carvedilol and processes for their preparation
12/04/2003WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
12/04/2003US20030225378 Mixing device for surgical sealants, and method thereof
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 295